{"id":"https://openalex.org/W4200313648","doi":"https://doi.org/10.1182/blood-2021-152692","title":"Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes","display_name":"Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W4200313648","doi":"https://doi.org/10.1182/blood-2021-152692"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-152692","doi":"https://doi.org/10.1182/blood-2021-152692","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-152692","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029369362","display_name":"David Andrew Sallman","orcid":"https://orcid.org/0000-0003-0504-8233","observed_orcids":["https://orcid.org/0000-0003-0504-8233"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Sallman","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017961539","display_name":"Hany Elmariah","orcid":"https://orcid.org/0000-0001-7920-4636","observed_orcids":["https://orcid.org/0000-0001-7920-4636"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hany Elmariah","raw_affiliation_strings":["Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057933586","display_name":"Kendra Lynn Sweet","orcid":"https://orcid.org/0000-0001-6248-3317","observed_orcids":["https://orcid.org/0000-0001-6248-3317"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kendra Sweet","raw_affiliation_strings":["Department of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078822704","display_name":"Chetasi Talati","orcid":"https://orcid.org/0000-0002-2246-213X","observed_orcids":["https://orcid.org/0000-0002-2246-213X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chetasi Talati","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083687455","display_name":"Asmita Mishra","orcid":"https://orcid.org/0000-0003-3065-4294","observed_orcids":["https://orcid.org/0000-0003-3065-4294"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Asmita Mishra","raw_affiliation_strings":["Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067694492","display_name":"Cheryl A. Cox","orcid":"https://orcid.org/0000-0002-7830-2549","observed_orcids":["https://orcid.org/0000-0002-7830-2549"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheryl A Cox","raw_affiliation_strings":["Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079388220","display_name":"Roshanak Tolouei Semnani","orcid":"https://orcid.org/0000-0002-6129-0000","observed_orcids":["https://orcid.org/0000-0002-6129-0000"]},"institutions":[{"id":"https://openalex.org/I4210142788","display_name":"Precigen (United States)","ror":"https://ror.org/043h2ky09","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142788"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roshanak Semnani","raw_affiliation_strings":["Precigen, Germantown, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precigen, Germantown, MD","institution_ids":["https://openalex.org/I4210142788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082452338","display_name":"Rutul R. Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rutul R Shah","raw_affiliation_strings":["Precigen, Inc, Germantown, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precigen, Inc, Germantown, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109110971","display_name":"Helen Sabzevari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen Sabzevari","raw_affiliation_strings":["National Cancer Institute, National Institutes of Health, Bethesda, MD","Precigen, Inc, Germantown, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Precigen, Inc, Germantown, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018389032","display_name":"Marion Chakiath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142788","display_name":"Precigen (United States)","ror":"https://ror.org/043h2ky09","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142788"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marion Chakiath","raw_affiliation_strings":["Precigen, Germantown, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precigen, Germantown, MD","institution_ids":["https://openalex.org/I4210142788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090846657","display_name":"Justin Uthuppan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Uthuppan","raw_affiliation_strings":["Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084546808","display_name":"Amy R. Lankford","orcid":"https://orcid.org/0000-0001-9896-6193","observed_orcids":["https://orcid.org/0000-0001-9896-6193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy Lankford","raw_affiliation_strings":["Precigen, Inc., Germantown, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precigen, Inc., Germantown, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050418779","display_name":"Chen Wang","orcid":"https://orcid.org/0000-0003-4055-7391","observed_orcids":["https://orcid.org/0000-0003-4055-7391"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chen Wang","raw_affiliation_strings":["Department of Internal Medicine, University of South Florida, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of South Florida, Tampa, FL","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041754278","display_name":"Eric Padron","orcid":"https://orcid.org/0000-0002-4707-7916","observed_orcids":["https://orcid.org/0000-0002-4707-7916"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Padron","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047764826","display_name":"Andrew Tucker Kuykendall","orcid":"https://orcid.org/0000-0002-9040-7415","observed_orcids":["https://orcid.org/0000-0002-9040-7415"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew T. Kuykendall","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010075752","display_name":"Rami S. Komrokji","orcid":"https://orcid.org/0000-0002-1876-5269","observed_orcids":["https://orcid.org/0000-0002-1876-5269"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rami S. Komrokji","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041443589","display_name":"Jeffrey E. Lancet","orcid":"https://orcid.org/0000-0002-7751-7310","observed_orcids":["https://orcid.org/0000-0002-7751-7310"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey E. Lancet","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040390930","display_name":"Marco L. Davila","orcid":"https://orcid.org/0000-0002-6270-3065","observed_orcids":["https://orcid.org/0000-0002-6270-3065"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marco L. Davila","raw_affiliation_strings":["Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065360941","display_name":"Nelli Bejanyan","orcid":"https://orcid.org/0000-0003-0194-7338","observed_orcids":["https://orcid.org/0000-0003-0194-7338"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nelli Bejanyan","raw_affiliation_strings":["Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"825","last_page":"825"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7567999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7567999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.21639999747276306,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.640999972820282},{"id":"https://openalex.org/keywords/cd33","display_name":"CD33","score":0.875},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9020000100135803},{"id":"https://openalex.org/keywords/chronic-myelomonocytic-leukemia","display_name":"chronic myelomonocytic leukemia","score":0.9739999771118164},{"id":"https://openalex.org/keywords/membrane-bound-il-15","display_name":"membrane-bound IL-15","score":0.8500000238418579},{"id":"https://openalex.org/keywords/kill-switch","display_name":"kill switch","score":0.6610000133514404},{"id":"https://openalex.org/keywords/nonviral-gene-delivery","display_name":"non-viral gene delivery","score":0.847000002861023},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.7580000162124634},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.7839999794960022},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.7639999985694885},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9900000095367432},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4650000035762787},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.5979999899864197},{"id":"https://openalex.org/keywords/autologous-t-cells","display_name":"autologous T cells","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7377706170082092},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.6101901531219482},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5661419630050659},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5250266194343567},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.48837512731552124},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4804908335208893},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.46437138319015503},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.46327754855155945},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.457131028175354},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4500381350517273},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4389106035232544},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4298500418663025},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36728447675704956},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.2861151099205017},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22566485404968262},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.2189795970916748},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.18591701984405518},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1051127016544342},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-152692","doi":"https://doi.org/10.1182/blood-2021-152692","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-152692","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3095878169","https://openalex.org/W2986905789","https://openalex.org/W4214752459","https://openalex.org/W3210596056","https://openalex.org/W2603659379","https://openalex.org/W7127632291","https://openalex.org/W4399519808","https://openalex.org/W4391610859","https://openalex.org/W4389218916","https://openalex.org/W4389247126"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Therapeutic":[2],"options":[3],"for":[4,168,576],"relapsed/refractory":[5],"(r/r)":[6],"acute":[7],"myeloid":[8,51],"leukemia":[9,131,645],"(AML)":[10],"and":[11,71,165,184,199,236,262,326,358,398,413,423,437,485,494,553,561,566,590,595,622,632,684,703,708],"hypomethylating":[12],"agent":[13],"(HMA)":[14],"failure":[15,124],"higher":[16,125,538],"risk":[17,126],"myelodysplastic":[18],"syndrome":[19,367],"(MDS)":[20],"are":[21,56,85,147],"limited":[22],"with":[23,79,120,133,179,204,240,252,260,355,379,396,451,477,499,509,546,618,625,642,668,689],"a":[24,241,253,269,344,418,507,598,626,640,680],"median":[25,242,254,419],"overall":[26],"survival":[27],"of":[28,44,115,158,196,207,219,244,255,264,279,287,329,337,372,420,432,446,470,535,585,629,675,687,726,737,748,762,774,789,803,817,828,841,853,864,875,889,950,997,1035,1048,1062,1075,1120,1141,1155],"<":[29,97,393],"6":[30,169,304,604],"months.":[31],"Although":[32],"chimeric":[33],"antigen":[34],"receptor":[35],"(CAR)":[36],"T":[37,94],"cell":[38,144],"therapy":[39],"has":[40,465,531,678],"revolutionized":[41],"the":[42,330,673],"treatment":[43,452],"B-cell":[45],"malignancies,":[46],"significant":[47,427],"challenges":[48],"exist":[49],"in":[50,96,117,202,232,343,370,376,392,429,474,487,506,516,539,555,597,639,693,922,932,940,966,1131,1167,1177,1186,1199,1210,1220,1230],"CAR":[52],"development.":[53],"PRGN-3006":[54,116,173,297,471,536,659,688],"UltraCAR-T":[55,83,660],"engineered":[57],"using":[58,92],"non-viral":[59],"gene":[60],"delivery":[61],"to":[62,74,190,268,302,324,333,363,402,502,522,543,593,701,711],"simultaneously":[63],"express":[64],"CD33":[65,663],"CAR,":[66],"membrane":[67],"bound":[68],"IL-15":[69,447],"(mbIL15)":[70],"kill":[72,331],"switch":[73,332],"be":[75,712],"effective":[76],"against":[77],"AML":[78,227],"improved":[80],"safety":[81],"profile.":[82],"cells":[84,95,661],"manufactured":[86],"at":[87,210,299,417,490,558,653],"medical":[88],"center's":[89],"cGMP":[90],"facility":[91],"autologous":[93],"48":[98],"hours":[99,395],"without":[100,156,175],"ex":[101],"vivo":[102],"expansion.":[103],"Methods:":[104],"A":[105],"Phase":[106],"1/1b":[107],"first-in-human":[108],"dose":[109,212,461,527],"escalation/dose":[110],"expansion":[111,469,683],"clinical":[112],"trial":[113],"(NCT03927261)":[114],"adult":[118],"pts":[119,228,265,280,288,373,587],"r/r":[121,226,267],"AML,":[122],"HMA":[123,270],"MDS":[127],"or":[128,178,273,319,728,739,750,764,776,791,805,819,830,843,855,866,877,891,952,999,1037,1050,1064,1077,1122,1143,1157],"chronic":[129],"myelomonocytic":[130],"(CMML)":[132],"\u2265":[134],"5%":[135],"blasts.":[136],"Pts":[137,248],"who":[138],"have":[139,229,310,519,664],"relapsed":[140,283],"post":[141,441],"allogeneic":[142],"stem":[143],"transplant":[145,155],"(SCT)":[146],"allowed":[148],"if":[149],">":[150],"3":[151,256,384,586,637,649],"months":[152,504,569,605,638],"out":[153],"from":[154],"evidence":[157],"active":[159],"graft":[160],"versus":[161],"host":[162],"disease":[163,601],"(GvHD)":[164],"off":[166],"immunosuppression":[167],"weeks.":[170],"Ps":[171],"receive":[172],"infusion":[174,298],"(Cohort":[176,347],"1)":[177,389],"lymphodepletion":[180],"(fludarabine":[181],"30mg/m":[182],"2":[183,187,200,238,339,541,578,609,630],"cyclophosphamide":[185],"500mg/m":[186],"days":[188,407,421],"-5":[189],"-3;":[191],"Cohort":[192,208,233,237,388,459,525,540,544,577],"2).":[193],"Dose":[194],"escalation":[195,462,528],"Cohorts":[197],"1":[198,209,234,381,518,545,584,616,633,715],"occur":[201],"parallel":[203],"initial":[205],"clearance":[206,624],"each":[211],"level":[213],"(DL;":[214],"Table":[215],"1).":[216,647],"Results:":[217],"As":[218],"July":[220],"25,":[221],"2021,":[222],"data":[223,654,710],"cut-off,":[224],"15":[225],"been":[230,311,466,520,532,665,679],"treated":[231,695],"(n=9)":[235],"(n=6)":[239,281],"age":[243],"60":[245],"years":[246],"(33-77).":[247],"were":[249,289],"heavily":[250],"pre-treated":[251],"prior":[257],"regimens":[258],"(1-7),":[259],"93%":[261,286],"80%":[263],"being":[266],"+":[271],"venetoclax":[272],"intensive":[274],"chemotherapy,":[275],"respectively.":[276,425],"Additionally,":[277],"40%":[278],"had":[282],"after":[284],"SCT.":[285],"int/adv":[290],"by":[291],"ELN":[292],"2017":[293],"criteria":[294],"(60%":[295],"adverse).":[296],"doses":[300],"up":[301,501],"1x10":[303],"cells/kg":[305],"was":[306,341,405,439,472,537,579,591],"well":[307,666],"tolerated.":[308],"There":[309],"no":[312,327],"deaths,":[313],"DLTs,":[314],"bone":[315],"marrow":[316],"aplasia,":[317],"neurotoxicity":[318],"unexpected":[320],"on-target/off-target":[321],"toxicities":[322],"related":[323],"PRGN-3006,":[325],"use":[328],"date.":[334,523],"One":[335],"incidence":[336],"grade":[338,383,670],"GvHD":[340],"observed":[342,440,473,521],"post-SCT":[345,610],"patient":[346,361,641],"2)":[348],"on":[349,722,733,744,758,770,785,799,813,824,837,849,860,871,885,946,993,1031,1044,1058,1071,1116,1137,1151],"day":[350],"31,":[351],"which":[352],"resolved":[353,391],"completely":[354],"corticosteroid":[356],"therapy,":[357],"notably":[359],"this":[360],"responded":[362],"therapy.":[364],"Cytokine":[365],"release":[366],"(CRS)":[368],"occurred":[369,416],"47%":[371],"(n=7;":[374],"G1":[375],"5":[377],"pts)":[378],"only":[380],"transient":[382],"event":[385],"(DL":[386],"1,":[387,460],"that":[390,635],"24":[394],"tocilizumab":[397],"dexamethasone.":[399],"Median":[400],"onset":[401],"maximum":[403],"CRS":[404],"11":[406],"(range":[408],"4-15":[409],"days).":[410],"Peak":[411],"CRP":[412],"ferritin":[414],"levels":[415,431,445],"8":[422],"9,":[424],"No":[426,513],"increase":[428,450],"plasma":[430,444],"inflammatory":[433],"cytokines,":[434],"including":[435],"IL-6":[436],"TNFa,":[438],"treatment.":[442],"The":[443,571],"did":[448],"not":[449,456],"confirming":[453],"mbIL15":[454],"is":[455,699],"shed.":[457],"In":[458,524,672],"through":[463,529],"DL3":[464,486],"completed.":[467,533],"Dose-dependent":[468],"all":[475],"patients":[476,612,694],"mean":[478,547],"peak":[479,548],"copy":[480,549],"numbers":[481,550],"following":[482,551,696],"DL1,":[483,583],"DL2":[484,530,554],"peripheral":[488,556],"blood":[489,557],"approximately":[491,559],"600,":[492],"9,700":[493],"28,000":[495],"copies/\u00b5g":[496,563],"DNA,":[497,564],"respectively,":[498,565],"persistence":[500,567,686],"7":[503],"post-infusion":[505],"pt":[508],"stable":[510],"disease/blast":[511],"reduction.":[512],"objective":[514,572],"responses":[515,691],"cohort":[517],"2,":[526],"Expansion":[534],"compared":[542],"DL1":[552],"11,000":[560],"120,000":[562],"3+":[568],"post-infusion.":[570],"response":[573],"rate":[574],"(ORR)":[575],"50%":[580],"(3/6).":[581],"At":[582,607],"obtained":[588,614],"CRi":[589],"bridged":[592],"SCT":[594],"remains":[596],"measurable":[599],"residual":[600],"negative":[602],"CR":[603],"post-SCT.":[606],"DL2,":[608],"relapse":[611],"also":[613],"response:":[615],"CRh":[617],"complete":[619],"cytogenetic":[620],"remission":[621,627],"NGS":[623],"length":[628],"months;":[631],"PR":[634],"lasted":[636],"isolated":[643],"extramedullary":[644],"(Figure":[646],"All":[648],"responders":[650],"remain":[651],"alive":[652],"cut-off":[655],"(5-10":[656],"months).":[657],"Conclusion:":[658],"targeting":[662],"tolerated":[667],"low":[669],"CRS.":[671],"setting":[674],"mbIL15,":[676],"there":[677],"dose-dependent":[681],"robust":[682],"durable":[685],"encouraging":[690],"(50%)":[692],"lymphodepletion.":[697],"Enrollment":[698],"ongoing":[700],"DL4,":[702],"updated":[704],"safety,":[705],"efficacy,":[706],"PK/PD":[707],"cytokine":[709],"presented.":[713],"Figure":[714,716],"1.":[717],"Disclosures":[718],"Sallman:":[719],"AbbVie:":[720,895,1053,1087],"Membership":[721,732,743,757,769,784,798,812,823,836,848,859,870,884,945,992,1030,1043,1057,1070,1115,1136,1150],"an":[723,734,745,759,771,786,800,814,825,838,850,861,872,886,947,994,1032,1045,1059,1072,1117,1138,1152],"entity's":[724,735,746,760,772,787,801,815,826,839,851,862,873,887,948,995,1033,1046,1060,1073,1118,1139,1153],"Board":[725,736,747,761,773,788,802,816,827,840,852,863,874,888,949,996,1034,1047,1061,1074,1119,1140,1154],"Directors":[727,738,749,763,775,790,804,818,829,842,854,865,876,890,951,998,1036,1049,1063,1076,1121,1142,1156],"advisory":[729,740,751,765,777,792,806,820,831,844,856,867,878,892,953,1000,1038,1051,1065,1078,1123,1144,1158],"committees;":[730,741,752,766,807,821,845,857,868,879,1039,1052,1079,1124,1145,1159],"Syndax:":[731],"Intellia:":[742],"Incyte:":[753,975,1020],"Speakers":[754,779,902,905,1010,1014,1018,1067,1084],"Bureau;":[755,780,903,1011,1015,1019,1068],"Kite:":[756],"Bristol-Myers":[767],"Squibb:":[768,882],"committees,":[778,793,1001,1066],"Magenta:":[781,1134],"Consultancy;":[782,809,1021,1027,1054,1081,1088,1091,1094,1097,1099,1101,1103,1105,1192],"Aprea:":[783],"Research":[794,909,973,976,981,1002,1005,1110],"Funding;":[795,974,977,982,1003,1006],"Shattuck":[796],"Labs:":[797],"Takeda:":[808],"Novartis:":[810,834,908,1016,1040],"Consultancy,":[811,847,991,1041,1056,1083,1114,1135,1149],"Agios:":[822,1100],"committees.":[832,893,954],"Sweet:":[833],"Honoraria,":[835,883,1009,1013,1017,1042],"Astellas:":[846,904,1098],"Gilead:":[858],"AROG:":[869],"Bristol":[880],"Meyers":[881],"Talati:":[894],"Honoraria;":[896,898,900,971,979,987,989],"BMS:":[897,980],"Pfizer:":[899],"Jazz:":[901,1082,1106],"Bureau.":[906,1085],"Mishra:":[907],"Funding.":[910,1111],"Semnani:":[911],"Precigen:":[912,916,926,956,960,1109],"Current":[913,917,919,927,929,937,957,961,963,1128,1164,1174,1183,1196,1207,1217,1227],"Employment.":[914,958],"Shah:":[915],"Employment,":[918,928,962],"equity":[920,930,938,964,1129,1165,1175,1184,1197,1208,1218,1228],"holder":[921,931,939,965,1130,1166,1176,1185,1198,1209,1219,1229],"publicly-traded":[923,933,941,967,1132,1168,1178,1187,1200,1211,1221,1231],"company.":[924,968,1232],"Sabzevari:":[925],"company;":[934,942,1133,1169,1179,1188,1201,1212,1222],"Compass":[935],"Therapeutics:":[936],"Kinnate":[943],"BioPharma:":[944],"Chakiath:":[955],"Lankford:":[959],"Padron:":[969],"Stemline:":[970],"Kura:":[972],"Blueprint:":[978],"Taiho:":[983],"Honoraria.":[984,1024],"Kuykendall:":[985],"PharmaEssentia:":[986,1069],"Abbvie:":[988],"Protagonist:":[990],"Prelude:":[1004],"BluePrint":[1007],"Medicines:":[1008],"Celgene/BMS:":[1012,1102],"CTI":[1022],"Biopharma:":[1023],"Komrokji:":[1025],"Geron:":[1026],"Taiho":[1028],"Oncology:":[1029],"BMSCelgene:":[1055],"Acceleron:":[1080],"Lancet:":[1086],"Daiichi":[1089],"Sankyo:":[1090],"Millenium":[1092],"Pharma/Takeda:":[1093],"ElevateBio":[1095],"Management:":[1096],"BerGenBio:":[1104],"Consultancy.":[1107],"Davila:":[1108],"Bejanyan:":[1112],"Medexus:":[1113],"Avrobio":[1125],"(Spouse":[1126,1147,1162,1172,1181,1190,1194,1205,1215,1225],"disclosure):":[1127,1148,1163,1173,1182,1191,1195,1206,1216,1226],"Humanigen":[1146],"Crispr":[1160],"Therapeutics":[1161],"Teladoc":[1170],"Health":[1171],"Organon":[1180],"Kadmon":[1189],"Merck":[1193],"American":[1202],"Well":[1203],"Corp":[1204],"Thermo":[1213],"Fisher":[1214],"Unitedhealth":[1223],"Group":[1224]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-12-31T00:00:00"}